Eversept Partners LP purchased a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 28,577 shares of the company’s stock, valued at approximately $3,918,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mariner LLC increased its holdings in shares of National HealthCare by 0.9% in the fourth quarter. Mariner LLC now owns 6,839 shares of the company’s stock valued at $938,000 after purchasing an additional 59 shares during the last quarter. ProShare Advisors LLC raised its holdings in National HealthCare by 3.3% in the 4th quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock valued at $338,000 after acquiring an additional 78 shares during the period. State of Alaska Department of Revenue raised its holdings in National HealthCare by 2.2% in the 4th quarter. State of Alaska Department of Revenue now owns 7,161 shares of the company’s stock valued at $981,000 after acquiring an additional 152 shares during the period. Quarry LP boosted its holdings in shares of National HealthCare by 171.9% during the third quarter. Quarry LP now owns 261 shares of the company’s stock worth $32,000 after acquiring an additional 165 shares during the period. Finally, Simplex Trading LLC grew its position in shares of National HealthCare by 140.0% in the fourth quarter. Simplex Trading LLC now owns 348 shares of the company’s stock valued at $48,000 after purchasing an additional 203 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.
Analyst Ratings Changes
NHC has been the topic of several research reports. Royal Bank Of Canada raised National HealthCare to a “hold” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy”.
National HealthCare Stock Down 0.5%
NHC opened at $191.10 on Thursday. National HealthCare Corporation has a twelve month low of $93.54 and a twelve month high of $205.06. The company has a 50-day simple moving average of $182.37 and a 200 day simple moving average of $161.16. The stock has a market capitalization of $2.98 billion, a price-to-earnings ratio of 24.28 and a beta of 0.64.
National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.91 earnings per share for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%. The business had revenue of $381.82 million during the quarter.
National HealthCare Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.67 per share. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. This represents a $2.68 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Tuesday, June 30th. National HealthCare’s dividend payout ratio (DPR) is currently 59.12%.
Insiders Place Their Bets
In other news, Director Lisa Piercey acquired 949 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average price of $184.26 per share, with a total value of $174,862.74. Following the completion of the transaction, the director directly owned 949 shares of the company’s stock, valued at $174,862.74. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 13.92% of the stock is owned by corporate insiders.
National HealthCare Company Profile
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Featured Articles
- Five stocks we like better than National HealthCare
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
